Ftse Mib
33.791,39
0,13%
DAX
17.908,72
-0,07%
S&P 500
5.038,92
0,41%
NASDAQ
15.686,19
0,52%
Bitcoin
59.147,30
1,56%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Abeona Therapeutics Inc (ABEO) Abeona Therapeutics Inc (ABEO) Notizie

Abeona Therapeutics Inc

ABEO
3,85
-0,06 (-1,53%)
Ultimo aggiornamento: 16:47:05
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/4/202422:05GLOBEAbeona Therapeutics Provides Regulatory Update on Pz-cel
01/4/202414:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
18/3/202412:30GLOBEAbeona Therapeutics Reports Full Year 2023 Financial Results..
05/3/202413:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
14/2/202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202420:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:05GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
01/2/202413:30GLOBEAbeona Therapeutics Announces Progress Update on Pz-cel..
22/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202413:35EDGAR2Form 8-K - Current report
08/1/202413:30GLOBEAbeona Therapeutics Announces $50 Million Credit Facility
15/12/202313:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
04/12/202322:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202313:30EDGAR2Form 8-K - Current report
27/11/202313:30GLOBEAbeona Therapeutics Announces FDA Accepts and Grants..
13/11/202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:35EDGAR2Form 8-K - Current report
13/11/202313:30GLOBEAbeona Therapeutics Reports Third Quarter 2023 Financial..
01/11/202312:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
18/10/202313:30EDGAR2Form 8-K - Current report
17/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202322:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202323:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202313:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202313:30GLOBEAbeona Therapeutics Submits Biologics License Application to..
22/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202313:30GLOBEAbeona Therapeutics Appoints Madhav Vasanthavada, Ph.D.,..
07/9/202313:30GLOBEAbeona Therapeutics Announces Participation in Upcoming..
30/8/202313:30GLOBEAbeona Therapeutics Announces Positive Pre-BLA Meeting with..
08/8/202314:30EDGAR2Form 8-K - Current report
08/8/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:30GLOBEAbeona Therapeutics Reports Second Quarter 2023 Financial..
28/7/202313:30GLOBEAbeona Therapeutics Announces Submission of Briefing Package..
26/7/202302:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/7/202314:30GLOBEAbeona Therapeutics Joins Rare Disease Company Coalition
10/7/202316:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/7/202314:41EDGAR2Form 8-K - Current report
07/7/202314:30GLOBEAbeona Therapeutics Announces Closing of $25 Million..
Apertura: 4,00 Min: 3,84 Max: 4,00
Chiusura: 3,91

La tua Cronologia

NASDAQ
ABEO
Abeona Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network